Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash Flows From Operating Activities:
Net loss	$ (8,771,987)	$ (9,574,987)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability	(858)	(24,370)
Change in fair value of investment option liability	(1,707)	(21,620)
Stock-based compensation	827,323	1,562,392
Deferred offering costs expensed		418,200
Amortization of intangibles	42,182	168,750
Depreciation expense	158,676	168,739
Other	(99,230)
Change in operating assets and liabilities:
Prepaid expenses and other current assets	250,938	178,496
Accounts payable, accrued expenses and other liabilities	(413,864)	(834,630)
Due to related parties	(133,016)	232,891
Net cash used in operating activities	(8,141,543)	(7,726,139)
Cash Flows From Financing Activities:
Proceeds from sale of Common Stock and warrants, net of offering costs	4,244,467
Proceeds from Common Stock sold for cash pursuant to the ATM Agreement, net of offering costs	1,636,799
Proceeds from the exercise and inducement of Series A, B, C, and D warrants, net of offering costs	4,698,241	2,676,980
Proceeds from Common Stock sold under the Equity Distribution Agreement, net of offering costs		2,290,186
Proceeds from Common Stock sold under the Purchase Agreement, net of offering costs		1,083,706
Proceeds from the subscription receivable related to the issuance of Inducement Warrants and the exercise of warrants and preferred investment options		1,804,819
Payment for offering costs previously accrued		(181,857)
Net cash provided by financing activities	10,579,507	7,673,834
Effect of foreign exchange rate on changes on cash	(1,499)	5,354
Net increase (decrease) in cash	2,436,465	(46,951)
Cash at beginning of year	2,241,026	2,287,977
Cash at end of year	4,677,491	2,241,026
Supplemental disclosure of cash flow transactions:
Cash paid for interest
Income taxes paid		5,000
Non-cash financing and investing activities:
Non-cash issuance of round-up shares	860
Non-cash issuance of RSA vested shares	393
Offering costs accrued not paid	64,588
Deferred offering costs not paid	5,000
Deemed dividend on inducement of warrants	3,359,485
Issuance of Placement Agent Warrants as offering costs	364,000
Issuance of common shares for offering costs		771,293
Deferred offering costs charged to offering costs		$ 612,000